Prot #VRXP-A202: A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination with VTX-2337 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/26/13 → 11/26/16

Funding

  • PRA Health Sciences (Prot #VRXP-A202 // Prot #VRXP-A202)
  • VentiRx Pharmaceuticals, Inc. (Prot #VRXP-A202 // Prot #VRXP-A202)